Chris Spivey is director of Industry Relations and Strategic Partnership, MJH Life Sciences.

Videos

Laks Pernenkil, Brian Feth, and Alex Philippidis go behind the headlines to discuss the impact of recent news, including FDA’s drug shortage list update, Nobel prize winners in microRNA and AI, and a big-potential research win for RNA editing. 

Behind the Headlines: GLP-1 Shortage, Nobel Prize, RNA Editing, and More

Cell and gene therapy experts Fabian Gerlinghaus, Dr. Claudia Zylberberg, and Benjamin McLeod weigh in on hot topics in CGT. 

Buy, Sell, Hold: Cell and Gene Therapy - Part 3

Buy, Sell, Hold: Cell and Gene Therapy - Part 2

Buy, Sell, Hold: Cell and Gene Therapy - Part 1

Part of the session "Transforming Medicine: Unleashing the Potential of Cell and Gene Therapies," Sadelain discusses CAR-T cells for immunotherapy and the future of cell/gene therapies.

Living Drugs for Immunotherapy (PDA/FDA Joint Regulatory Conference 2023)

Articles

Biopharma industry faces production challenges as gene therapies move from clinical to commercialization.

Bringing Gene Therapies to Market

Mass-produce cell and gene therapies presents the biopharma industry with a unique set of challenges.

Gene Therapy Production Must Pass Regulatory Hurdles

Pylote SA discusses its Pyclear Protection packaging innovation.

CPhI 2016 Excellence in Pharma: Packaging Award Winner Interview

Andrew Bulpin, head of Process Solutions Strategic Marketing and Innovation, MilliporeSigma discusses the company's Emprove Program, winner of the 2016 CPhI Award for Regulatory Procedures and Compliance. 




PharmTech Videos